Femara Content Anti Estrogen Steroids , CAS : 112809-51-5

본문 바로가기


Home > Product > Femara Content Anti Estrogen Steroids , CAS : 112809-51-5
Selling leads
Femara Content Anti Estrogen Steroids , CAS : 112809-51-5
Posting date : Mar 06, 2015
Membership
Free Member Scince Dec 22, 2014
FOB Price
1 Letrozole
Min. Order Quantity
10g Letrozole
Supply Abillity
2000kg per month Letrozole
Port
Shanghai,Shenzhen,Hongkong
Payment Terms
T/T,Western Union,Money Gram
Package
Discreet ways of packing for Custom pass guaranteed
Keyword :
Category
Contact
hannah
Selling Leads Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
Brand Name
Steroid Letrozole
Model Number
112809-51-5
HS-CODE
30-
Package & Delivery Lead Time
Package
Discreet ways of packing for Custom pass guaranteed
Delivery Lead Time
within 24 hours after the payment
Detailed Description
Femara Content Anti Estrogen Steroids , CAS : 112809-51-5
hannah(at)chembj(dot)com  skypeID: live:hannah_2165
Detailed Product Description
 
Alias::
112809-51-5
Assay(by HPLC):
98%
CAS NO.:
Letrozole
Purity:
98%
Product Name:
Anti Estrogen Steroid Powder
Application:
Women, Men
 
 
Description:
 
Letrozole
Alias: Femara
CAS No: 112809-51-5
MF: C17H11N5
MW: 285.3
 
 
Purity: 98%
Appearance: white powder.
 
 
You need Letrozole Femara ???
 
 
1.Femara (letrozole) is a type II (non-steroidal) third generation aromatase inhibitor. Clinically it is used to treat postmenopausal women with either estrogen receptor positive or estrogen receptor unknown breast cancer.
In women with breast cancer, it has been shown to reduce estrogen levels by 98% or more (1). However, it’s use and benefits are not limited to eliminating estrogen in women.
For pre-contest bodybuilders, Letrozole is almost a necessity to eliminate water retention and achieve the ripped look necessary to compete in today’s bodybuilding world. However, in my experience, it is only necessary to be used for the last 4-6 weeks, to eliminate excess estrogen and water retention. After using Letrozole I recommend staying away from any estrogen suppression for at least a month to try to normalize the body.
 
 2. Letrozole is used to treat postmenopausal women with hormone receptor positive early breast cancer or who have been treated with tamoxifen (Nolvadex). It also is approved for initial or second-line treatment of postmenopausal women with hormone-sensitive or advanced breast cancer.
 
Specifications:
 
Tests
Specifications
Results
Appearance
White or off-white crystaline powder
White
Crystalline powder
Solubility
 
Soluble in Chloroform;
Soluble in ethanol when heated
Conform
ldentification
(1)Maximum absorption in wavelength of 240 nm
Minimum absorption in wavelength of 215 nm
Conform
Conform
(2)Infrared spectrum should be in accordance the dominant peak of contrast
In accordance with the dominant peak of contrast
Melting points
182℃-184℃
182℃
Related substances
≤0.5%
0.3%
Single impurity
≤0.3%
0.2%
Loss on drying
≤1.0%
0.8%
[Assay]C17H11N5
(On anhydrous basis)
≥98.0%
99.2%
Conclusion
Conforms Specifications of Enterprise Standard.
 
 
competitive advantage :
We produce letrozole for the treatment of early breast cancer who have undergone menopause (change of life, the end of monthly menstrual cycle), women who have had other treatments, such as radiation therapy or surgery to remove the tumor, through our years of experience and a long years of exploration, our quality is very reliable, and safe, efficient mode of transport, our products are subject to a number of customers.
Keyword
 
1.Letrozole Femara 
2. Letrozole
 
 
 Relations product
 
Relations product:
Name
Anastrozole  Arimidex
   Exemestan
Letrozole
tamoxifen citrate
Clomiphene Citrate
CAS
120511-73-1
107868-30-4
112809-51-5
10540-29-1
 50-41-9
 
 
Tag: Letrozole and Femara  Content Anti Estrogen Steroids
 

ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2024 ECROBOT.COM. All rights reserved.
Top